Is Colchicine a New Game-Changer in Patients With Acute Coronary Syndrome?

Colchicine, an anti-inflammatory drug, was declared as a potently cheap and effective drug in treating atherosclerosis. This report is a detailed understanding and an in-depth interpretation of the colchicine cardiovascular outcomes trial (COLCOT) that has taken place in recent years. It is a second...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawabi, Abdul Q, Hassan, Warda, Chen, Lijuan, Shaikh, Naveed, Abbas, Kiran, Zehra, Fatima T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980200/
https://www.ncbi.nlm.nih.gov/pubmed/35399435
http://dx.doi.org/10.7759/cureus.22874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980200/
https://www.ncbi.nlm.nih.gov/pubmed/35399435
http://dx.doi.org/10.7759/cureus.22874

Ejemplares similares